QEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with major Depressive Disorder

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43909410" target="_blank" >RIV/00216208:11120/15:43909410 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023752:_____/15:43914646

Výsledek na webu

<a href="http://dx.doi.org/10.1177/1550059413520442" target="_blank" >http://dx.doi.org/10.1177/1550059413520442</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1177/1550059413520442" target="_blank" >10.1177/1550059413520442</a>

Jazyk výsledku

angličtina

Název v původním jazyce

QEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with major Depressive Disorder

Popis výsledku v původním jazyce

The aims of this double-blind study were to assess and compare the efficacy of quantitative electroencephalographic (QEEG) prefrontal theta band cordance in the prediction of response to 4-week, right, prefrontal, 1-Hz repetitive transcranial magnetic stimulation (rTMS) or venlafaxine ER in patients with major depressive disorder (MDD). Prefrontal QEEG cordance values of 50 inpatients (25 subjects in each group) completing 4 weeks of the study were obtained at baseline and after 1 week of treatment. Depressive symptoms were assessed using Montgomery-?sberg Depression Rating Scale (MADRS) at baseline and at week 1 and 4. Treatment response was defined as a GREATER-THAN OR EQUAL TO50% reduction in baseline MADRS total score. All responders (n = 9) and 6of 16 nonresponders in the rTMS group had reduced cordance at week 1 (P < .01). Reduction of theta cordance value at week 1 was detected in all responders (n = 10) to venlafaxine ER, but only in 4 of 15 nonresponders (P = .005). The compa

Název v anglickém jazyce

QEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with major Depressive Disorder

Popis výsledku anglicky

The aims of this double-blind study were to assess and compare the efficacy of quantitative electroencephalographic (QEEG) prefrontal theta band cordance in the prediction of response to 4-week, right, prefrontal, 1-Hz repetitive transcranial magnetic stimulation (rTMS) or venlafaxine ER in patients with major depressive disorder (MDD). Prefrontal QEEG cordance values of 50 inpatients (25 subjects in each group) completing 4 weeks of the study were obtained at baseline and after 1 week of treatment. Depressive symptoms were assessed using Montgomery-?sberg Depression Rating Scale (MADRS) at baseline and at week 1 and 4. Treatment response was defined as a GREATER-THAN OR EQUAL TO50% reduction in baseline MADRS total score. All responders (n = 9) and 6of 16 nonresponders in the rTMS group had reduced cordance at week 1 (P < .01). Reduction of theta cordance value at week 1 was detected in all responders (n = 10) to venlafaxine ER, but only in 4 of 15 nonresponders (P = .005). The compa

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FH - Neurologie, neurochirurgie, neurovědy

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical EEG and Neuroscience

ISSN

1550-0594

e-ISSN

—

Svazek periodika

46

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

8

Strana od-do

73-80

Kód UT WoS článku

000355489200001

EID výsledku v databázi Scopus

—